Article

Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a…

International Journal of Chronic Obstructive Pulmonary Disease · 2020 · Rowe SM, Jones I, Dransfield MT, Haque N, Gleason S, Hayes KA, Kulmatycki K, Yates DP, Danahay H, Gosling M, Rowlands DJ, Grant SS

Key facts

Title Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial
First author Rowe SM, Jones I, Dransfield MT, Haque N, Gleason S, Hayes KA, Kulmatycki K, Yates DP, Danahay H, Gosling M, Rowlands DJ, Grant SS
Journal International Journal of Chronic Obstructive Pulmonary Disease
Published Oct 5, 2020
DOI 10.2147/COPD.S257474
Devices mentioned 201404, 201512, 201806, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184 and 4 more
Product codes mentioned CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 4 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature